Long-term outcomes of PE by health status (n = 150)
| Outcomes . | No underlying conditions, n = 58∗ . | Underlying conditions present, n = 92∗ . | P value† . |
|---|---|---|---|
| Nonresolution of PE at follow-up‡ | 14 (26%) | 26 (32%) | .47 |
| Recurrence | 1 (1.7%) | 12 (13%) | .016 |
| Death | 1 (1.7%) | 6 (6.5%) | .25 |
| Dyspnea or increased work of breathing | |||
| Chronic | 3 (5.2%) | 7 (7.6%) | .84 |
| Transient | 12 (21%) | 17 (18%) | |
| Abnormal echocardiogram findings§ | |||
| Chronic | 1 (1.9%) | 5 (5.8%) | .11 |
| Transient | 1 (1.9%) | 8 (9.3%) | |
| Chronic thromboembolic pulmonary hypertension | 0 (0%) | 1 (1.1%) | >.99 |
| Post-PE cardiac impairment§ | 0 (0%) | 1 (1.2%) | >.99 |
| Post-PE functional impairment‖ | 2 (7.1%) | 3 (9.7%) | >.99 |
| Outcomes . | No underlying conditions, n = 58∗ . | Underlying conditions present, n = 92∗ . | P value† . |
|---|---|---|---|
| Nonresolution of PE at follow-up‡ | 14 (26%) | 26 (32%) | .47 |
| Recurrence | 1 (1.7%) | 12 (13%) | .016 |
| Death | 1 (1.7%) | 6 (6.5%) | .25 |
| Dyspnea or increased work of breathing | |||
| Chronic | 3 (5.2%) | 7 (7.6%) | .84 |
| Transient | 12 (21%) | 17 (18%) | |
| Abnormal echocardiogram findings§ | |||
| Chronic | 1 (1.9%) | 5 (5.8%) | .11 |
| Transient | 1 (1.9%) | 8 (9.3%) | |
| Chronic thromboembolic pulmonary hypertension | 0 (0%) | 1 (1.1%) | >.99 |
| Post-PE cardiac impairment§ | 0 (0%) | 1 (1.2%) | >.99 |
| Post-PE functional impairment‖ | 2 (7.1%) | 3 (9.7%) | >.99 |